SpyGlass Pharma stock analysis
SpyGlass Pharma (SGP) Stock Price & Analysis
SGP Stock Chart & Stats
- Day’s Range
- $30.53 - $32.81
- 52-Week Range
- $17.06 - $39.92
- Previous Close
- $32.24
- Volume
- N/A
- Average Volume (3M)
- 103.85K
- Market Cap
- $1.05B
- Enterprise Value
- $655.58M
- Total Cash (Recent Filing)
- $215.76M
- Total Debt (Recent Filing)
- $1.61M
- Price to Earnings (P/E)
- ―
- Beta
- 0.35
- Next Earnings
- May 20, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
SpyGlass Pharma News
SpyGlass Pharma: De-risked BIM-IOL Platform Poised to Reshape Glaucoma Treatment and Drive Upside to Conservative Peak Sales Estimates
Yigal Nochomovitz, an analyst from Citi, has initiated a new Buy rating on SpyGlass Pharma (SGP). Yigal Nochomovitz has given his Buy rating due to a combination of factors, starting
SGP FAQ
What was SpyGlass Pharma’s price range in the past 12 months?
What is SpyGlass Pharma’s market cap?
When is SpyGlass Pharma’s upcoming earnings report date?
How were SpyGlass Pharma’s earnings last quarter?
Is SpyGlass Pharma overvalued?
Does SpyGlass Pharma pay dividends?
What is SpyGlass Pharma’s EPS estimate?
How many shares outstanding does SpyGlass Pharma have?
What happened to SpyGlass Pharma’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SpyGlass Pharma?
What is the TipRanks Smart Score and how is it calculated?
SpyGlass Pharma Stock Smart Score
Company Description
SpyGlass Pharma
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Patrick H. Mooney
- Employees
- 76
- Website
- www.spyglasspharma.com
- Address
- 15326 Alton Parkway, Irvine, CA, 92618, US
SpyGlass Pharma (SGP) Earnings & Revenues
SGP Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 6 | 7 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 4 | 0 | 6 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| CCMConcord Medical Services |









